Effects of Psidium guajava leaf extract on secretion systems of gram‐negative enteropathogenic bacteria

In this study, 672 plant‐tissue extracts were screened for phytochemicals that inhibit the function of the type III secretion system (T3SS) of enteropathogenic Escherichia coli (EPEC) and enterohemorrhagic E. coli (EHEC). Among candidates examined, an extract from the leaves of Psidium guajava (guava) was found to inhibit secretion of EPEC‐secreted protein B (EspB) from EPEC and EHEC without affecting bacterial growth. Guava extract (GE) also inhibited EPEC and EHEC from adhering to, and injecting EspB into, HEp‐2 cells. GE seemed to block translocation of EspB from the bacterial cells to the culture medium. In addition, GE also inhibited the T3SS of Yersinia pseudotuberculosis and Salmonella enterica serovar Typhimurium. After exposure to GE, Y. pseudotuberculosis stopped secreting Yersinia outer proteins and was unable to induce apoptosis of mouse bone marrow‐derived macrophages. S. typhimurium exposed to GE stopped secreting Sip proteins and was unable to invade HEp‐2 cells. GE inhibited secretion of EspC, the type V secretion protein of EPEC, but not secretion of Shiga toxin 2 from EHEC. Thus, our results suggest that guava leaves contain a novel type of antimicrobial compound that could be used to treat and prevent gram‐negative enteropathogenic bacterial infections.

[1]  K. Kovařčík,et al.  A proteomic approach to the development of DIVA ELISA distinguishing pigs infected with Salmonella Typhimurium and pigs vaccinated with a Salmonella Typhimurium-based inactivated vaccine , 2016, BMC Veterinary Research.

[2]  Lanping Zhu,et al.  Small-Molecule Inhibitors of the Type III Secretion System , 2015, Molecules.

[3]  B. Finlay,et al.  Bringing down the host: enteropathogenic and enterohaemorrhagic Escherichia coli effector‐mediated subversion of host innate immune pathways , 2015, Cellular microbiology.

[4]  T. Nicholson,et al.  The Bordetella bronchiseptica Type III Secretion System Is Required for Persistence and Disease Severity but Not Transmission in Swine , 2013, Infection and Immunity.

[5]  Martin J. Aryee,et al.  Global Causes of Diarrheal Disease Mortality in Children <5 Years of Age: A Systematic Review , 2013, PloS one.

[6]  P. Marsden,et al.  Shiga toxin-associated hemolytic uremic syndrome: advances in pathogenesis and therapeutics , 2012, Current opinion in nephrology and hypertension.

[7]  L. L. Nesse,et al.  Salmonella Typhimurium invasion of HEp-2 epithelial cells in vitro is increased by N-acylhomoserine lactone quorum sensing signals , 2011, Acta veterinaria Scandinavica.

[8]  J. Pearson,et al.  Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements , 2011, Molecular microbiology.

[9]  Y. Ogura,et al.  Detergents enhance EspB secretion from Escherichia coli strains harboring the locus for the enterocyte effacement (LEE) gene. , 2011, FEMS microbiology letters.

[10]  S. Ōmura,et al.  A small-molecule inhibitor of the bacterial type III secretion system protects against in vivo infection with Citrobacter rodentium , 2011, The Journal of Antibiotics.

[11]  C. Sittiwet,et al.  Antimicrobial properties of Derris scandens aqueous extract. , 2009 .

[12]  A. Blocker,et al.  Small-Molecule Type III Secretion System Inhibitors Block Assembly of the Shigella Type III Secreton , 2008, Journal of bacteriology.

[13]  Priyanka Singh,et al.  Assessment of Thymus vulgaris L. essential oil as a safe botanical preservative against post harvest fungal infestation of food commodities , 2008 .

[14]  R. Gutierrez,et al.  Psidium guajava: a review of its traditional uses, phytochemistry and pharmacology. , 2008, Journal of ethnopharmacology.

[15]  B. Finlay,et al.  Type III Secretion Systems and Disease , 2007, Clinical Microbiology Reviews.

[16]  Edouard E Galyov,et al.  Inhibition of Type III Secretion in Salmonella enterica Serovar Typhimurium by Small-Molecule Inhibitors , 2007, Antimicrobial Agents and Chemotherapy.

[17]  N. Nakasone,et al.  Development of a rapid immunochromatographic test to identify enteropathogenic and enterohemorrhagic Escherichia coli by detecting EspB. , 2007, Diagnostic microbiology and infectious disease.

[18]  M. Drago-Serrano,et al.  EspC, an autotransporter protein secreted by enteropathogenic Escherichia coli (EPEC), displays protease activity on human hemoglobin. , 2006, FEMS microbiology letters.

[19]  H. Wolf‐Watz,et al.  Small-Molecule Inhibitors Specifically Targeting Type III Secretion , 2005, Infection and Immunity.

[20]  C. Guzmán,et al.  Lactoferrin Impairs Type III Secretory System Function in Enteropathogenic Escherichia coli , 2003, Infection and Immunity.

[21]  M. Brigido,et al.  Evidence for the presence of a type III secretion system in diffusely adhering Escherichia coli (DAEC). , 2003, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[22]  I. Chinen,et al.  Multiplex PCR Assay for Identification of Human Diarrheagenic Escherichia coli , 2003, Journal of Clinical Microbiology.

[23]  B. Finlay,et al.  Secretin of the Enteropathogenic Escherichia coli Type III Secretion System Requires Components of the Type III Apparatus for Assembly and Localization , 2003, Infection and Immunity.

[24]  M. Iwanaga,et al.  Detection of EspB using reversed passive latex agglutination: application to determination of enteropathogenic Escherichia coli. , 2002, Diagnostic microbiology and infectious disease.

[25]  H. Wolf‐Watz,et al.  The type III secretion chaperone LcrH co‐operates with YopD to establish a negative, regulatory loop for control of Yop synthesis in Yersinia pseudotuberculosis , 2001, Molecular microbiology.

[26]  B. China,et al.  Comparison of eae, tir, espA and espB genes of bovine and human attaching and effacing Escherichia coli by multiplex polymerase chain reaction. , 1999, FEMS microbiology letters.

[27]  C. Hueck,et al.  Type III Protein Secretion Systems in Bacterial Pathogens of Animals and Plants , 1998, Microbiology and Molecular Biology Reviews.

[28]  S. Falkow,et al.  Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[29]  H. Wolf‐Watz,et al.  The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact‐dependent membrane disrupting activity. , 1996, The EMBO journal.

[30]  J. Galán,et al.  Salmonella spp. are cytotoxic for cultured macrophages , 1996, Molecular microbiology.

[31]  T. McDaniel,et al.  A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. Curtiss,et al.  Plasmid-associated virulence of Salmonella typhimurium , 1987, Infection and immunity.

[33]  T. Yutsudo,et al.  Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin. , 1987, Microbial pathogenesis.

[34]  R. Roeder,et al.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.

[35]  R. Finkelstein,et al.  Vibrio cholerae hemagglutinin/lectin/protease hydrolyzes fibronectin and ovomucin: F.M. Burnet revisited. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[36]  P. Gemski,et al.  Presence of a virulence-associated plasmid in Yersinia pseudotuberculosis , 1980, Infection and immunity.

[37]  E. Dowdle,et al.  Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. , 1980, Analytical biochemistry.

[38]  A. N. Adams,et al.  Characteristics of the microplate method of enzyme-linked immunosorbent assay for the detection of plant viruses. , 1977, The Journal of general virology.